p53 genetic abnormalities and myc activation in human lung carcinoma

No abstract is available for this paper.

• Publication year

  1994

• Venue

  International Journal of Cancer

• Publication date

  1994-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.2910580106PMID 8014012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of oncoproteins for the survival of patients with nonsmall cell lung carcinomas.

  1993cited by this paper
• Overexpression of the p53 Tumor Suppressor Gene Product in Primary Lung Adenocarcinomas Is Associated with Cigarette Smoking

  1993cited by this paper
• Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif.

  1993cited by this paper
• Squamous metaplasia expression of proto-oncogenes and P 53 in lung cancer patients.

  1993cited by this paper
• c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.

  1993cited by this paper
• p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes.

  1993cited by this paper
• Immunohistochemical study of p53 in human lung carcinomas.

  1993cited by this paper
• Basal cell (basaloid) carcinoma of the lung.

  1993cited by this paper
• The relationship of p53 immunostaining to survival in carcinoma of the lung.

  1992cited by this paper
• Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.

  1992cited by this paper
• Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.

  1992cited by this paper
• p53: the ultimate tumor suppressor gene?

  1992cited by this paper
• Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung.

  1992cited by this paper
• Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation.

  1992cited by this paper
• Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance.

  1992cited by this paper
• Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma.

  1992cited by this paper
• p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.

  1992cited by this paper
• High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors.

  1992cited by this paper
• Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation.

  1992cited by this paper
• Neuroendocrine Tumors of the Lung With Proposed Criteria for Large‐Cell Neuroendocrine Carcinoma: An Ultrastructural, Immunohistochemical, and Flow Cytometric Study of 35 Cases

  1991cited by this paper
• p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.

  1991cited by this paper
• Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice.

  1991cited by this paper
• The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern.

  1991cited by this paper
• Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

  1990cited by this paper
• Increased expression of mutant forms of p53 oncogene in primary lung cancer.

  1990cited by this paper
• p53: a frequent target for genetic abnormalities in lung cancer.

  1989cited by this paper
• The interstitial matrix of human carcinomas and sarcomas transplanted to the nude mouse: immunolocalization of some human and murine components.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

  1986cited by this paper

• The Effectiveness of Various Chemotherapeutic Agents in Cancer Treatment

  2022cites this paper
• Evaluate the Prognosis of MYC/TP53 Comutation in Chinese Patients with EGFR-Positive Advanced NSCLC Using Next-Generation Sequencing: A Retrospective Study

  2022cites this paper
• Does Bach1 & c-Myc dependent redox dysregulation of Nrf2 & adaptive homeostasis decrease cancer risk in ageing?

  2019cites this paper
• Sodium Valproate Inhibits Small Cell Lung Cancer Tumor Growth on the Chicken Embryo Chorioallantoic Membrane and Reduces the p53 and EZH2 Expression

  2018cites this paper
• Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.

  2017influential citation
• ICRP Publication 131: Stem Cell Biology with Respect to Carcinogenesis Aspects of Radiological Protection

  2015cites this paper
• Signaling Pathways and MicroRNA Changes in Nano-TiO2 Treated Human Lung Epithelial (BEAS-2B) Cells.

  2015cites this paper
• Molecular and biological characteristics of breast cancer

  2013cites this paper
• Expression of Molecular Markers in Tumours of Patients with Breast Cancer

  2013cites this paper
• Molecular biomarkers of lung carcinoma.

  2012influential citation
• The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

  2012cites this paper
• Relationship between NF-κB, ER, PR, Her2/neu, Ki67, p53 expression in human breast cancer.

  2012cites this paper
• Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosis

  2012cites this paper
• The role of the c-Jun N-terminal kinase 2-α-isoform in non-small cell lung carcinoma tumorigenesis

  2011cites this paper
• Epidermal Growth Factor Receptor Mutation and p53 Overexpression during the Multistage Progression of Small Adenocarcinoma of the Lung

  2010cites this paper
• The Role of Mutation and Epimutation in the Development of Human Disease

  2009cites this paper
• Biomarkers for Lung Cancer

  2009cites this paper
• Pulmonary preneoplasia – sequential molecular carcinogenetic events

  2009cites this paper
• Pathogenesis of lung cancer signalling pathways: roadmap for therapies

  2009cites this paper
• Proteomic approaches in lung cancer biomarker development

  2009cites this paper
• Roles of Mutation and Epimutation in the Development of Lung Disease

  2008cites this paper
• NON-VIRAL VECTORIZATION OF THERAPEUTIC MOLECULES FOR LUNG CANCER THERAPY

  2008cites this paper
• Small Cell Carcinoma

  2008cites this paper
• Molecular predictive factors for progression of high-grade preinvasive bronchial lesions.

  2008cites this paper
• Biomarkers for the lung cancer diagnosis and their advances in proteomics.

  2008cites this paper
• High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not.

  2007cites this paper
• Early Detection of Lung Cancer: A Call for Novel Biomarkers-Review

  2007cites this paper
• Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis

  2007cites this paper
• Silent Allel in Lung Cancer p 73 Activation of Updated Version

  2006cites this paper
• Activation of p73 Silent Alà elein Lung Cancer1

  2006cites this paper
• Molecular Biology and Genetics of Lung Cancer

  2005cites this paper
• Telomere Shortening and Telomerase Reverse Transcriptase Expression in Preinvasive Bronchial Lesions

  2005cites this paper
• Original Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: Follow-up study and prognostic significance

  2005cites this paper
• Mutant Immunophenotype and Deregulation of p 53 Transcription Pathway ( Bc 12 , Bax , and Waft ) in Precursor Bronchial Lesions of Lung Cancer 1

  2005cites this paper
• Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma.

  2005cites this paper
• Bases moléculaires de la progression tumorale dans les lésions prénéoplasiques bronchiques: Approches in situ

  2005cites this paper
• Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing

  2004cites this paper
• Senescence, apoptosis and therapy — cutting the lifelines of cancer

  2003cites this paper
• Investigation of c-myc and p53 Gene Alterations in the Tumor and Surgical Borderline Tissues of NSCLC and Effects on Clinicopathologic Behavior: By the FISH Technique

  2003cites this paper
• Early detection of lung cancer: role of biomarkers

  2003cites this paper
• Pathology of human bronchioloalveolar carcinoma and its relationship to the ovine disease.

  2003cites this paper
• Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumors

  2002cites this paper
• Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer

  2002cites this paper
• Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications

  2001cites this paper
• pRb2/p130 gene overexpression induces astrocyte differentiation.

  2001cites this paper
• Demethylation by 5-aza-2'-deoxycytidine (5-azadC) of p16INK4A gene results in downregulation of vascular endothelial growth factor expression in human lung cancer cell lines.

  2001cites this paper
• Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction.

  2001cites this paper
• Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma

  2001cites this paper
• Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction

  2001cites this paper
• Expression of the cdc25B gene as a prognosis marker in non-small cell lung cancer.

  2001cites this paper
• Immunohistochemical expression of the intracellular component of galectin-8 in squamous cell metaplasia of the bronchial epithelium in neoplastic and benign processes.

  2001cites this paper
• Current and Future Applications of Gene Therapy in Respiratory Disease

  2000cites this paper
• Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance.

  2000cites this paper
• P53 immunohistochemistry can identify bronchial dysplastic lesions proceeding to lung cancer: a prospective study.

  2000cites this paper
• Molecular and genetic aspects of lung cancer.

  2000cites this paper
• Prognostic relevance of c-Myc and caspase-3 for patients with non-small cell lung cancer.

  2000cites this paper
• DNA aneuploidy, S-phase fraction and nuclear p53 positivity in non-small cell lung carcinoma.

  1999cites this paper
• Use of Biochemical and Molecular Biomarkers for Cancer Risk Assessment in Humans

  1999cites this paper
• The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung.

  1999cites this paper
• p53 protein expression in conjunctival squamous cell carcinomas of domestic animals.

  1999cites this paper
• Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms.

  1999cites this paper
• Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers.

  1999cites this paper
• Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.

  1998cites this paper
• Expression of mdm-2 Protein in Neoplastic, Preneoplastic, and Normal Bronchial Mucosa Specimens: Comparative Study with p53 Expression

  1998cites this paper
• Advances in Brief Overexpression of cdc 25 A and cdc 25 B Is Frequent in Primary Non-Small Cell Lung Cancer but Is Not Associated with Overexpression of c-myc 1

  1998cites this paper
• High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.

  1998cites this paper
• Activation of p73 silent allele in lung cancer.

  1998cites this paper
• Analysis of loss of heterozygosity in small adenocarcinomas of the lung.

  1998cites this paper
• p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.

  1998cites this paper
• Effect of a 17-Member Azalide on Tumor Cell Growth

  1998cites this paper
• Serum anti-p53 autoantibodies in primary resected non-small-cell lung carcinoma

  1998cites this paper
• The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer.

  1998cites this paper
• Contiguous Four‐guanosine Sequence in c‐myc Antisense Phosphorothioate Oligonucleotides Inhibits Cell Growth on Human Lung Cancer Cells: Possible Involvement of Cell Adhesion Inhibition

  1997cites this paper
• p53 and lung cancer.

  1997cites this paper
• The molecular epidemiology of lung cancer.

  1997cites this paper
• Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.

  1996cites this paper
• Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.

  1996cites this paper
• K‐ras mutation in sputum of patients with or without lung cancer

  1996cites this paper
• Mécanismes de la carcinogenèse bronchique

  1996cites this paper
• Frequent TP53 gene alterations (mutation, allelic loss, nuclear accumulation) in primary non-small cell lung cancer.

  1996cites this paper
• p53 protein is absent from the serum of patients with lung cancer.

  1996influential citation
• Prognostic factors in resected non-small cell lung cancer: an immunohistochemical study of 39 cases.

  1996cites this paper
• Apoptosis occurs independently of bcl‐2 and p53 over‐expression in non‐small cell lung carcinoma

  1996cites this paper
• Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance.

  1995cites this paper
• Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas.

  1995cites this paper
• p53 immunolabeling in archival paraffin-embedded tissues: optimal protocol based on microwave heating for eight antibodies on lung carcinomas.

  1994cites this paper
• International Journal of Biological & Medical Research Carcinoma Lung---major Updates in Biomarkers for Early Diagnosis International Journal of Biological and Medical Research Www.biomedscidirect.com Int J Biol Med Res

  year unknowncites this paper
• Overexpression of MAGEA 2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer

  year unknowncites this paper